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Abstract
Background: According to the Chagas congenital transmission guides, the diagnosis of infants, born to Trypanosoma cruzi
infected mothers, relies on the detection of parasites by INP micromethod, and/or the persistence of T. cruzi specific
antibody titers at 10–12 months of age.
Methodology and Principal Findings: Parasitemia levels were quantified by PCR in T. cruzi-infected children, grouped
according to the results of one-year follow-up diagnosis: A) Neonates that were diagnosed in the first month after delivery
by microscopic blood examination (INP micromethod) (n = 19) had a median parasitemia of 1,700 Pe/mL (equivalent
amounts of parasite DNA per mL); B) Infants that required a second parasitological diagnosis at six months of age (n = 10)
showed a median parasitemia of around 20 Pe/mL and 500 Pe/mL at 1 and 6 months old, respectively, and C) babies with
undetectable parasitemia by three blood microscopic observations but diagnosed by specific anti - T. cruzi serology at
around 1 year old, (n = 22), exhibited a parasitemia of around 5 Pe/mL, 800 Pe/mL and 20 Pe/mL 1, 6 and 12 month after
delivery, respectively. T. cruzi parasites were isolated by hemoculture from 19 congenitally infected children, 18 of which
were genotypified as DTU TcV, (former lineage TcIId) and only one as TcI.
Significance: This report is the first to quantify parasitemia levels in more than 50 children congenitally infected with T.
cruzi, at three different diagnostic controls during one-year follow-up after delivery. Our results show that the parasite
burden in some children (22 out of 51) is below the detection limit of the INP micromethod. As the current trypanocidal
treatment proved to be very effective to cure T. cruzi - infected children, more sensitive parasitological methods should be
developed to assure an early T. cruzi congenital diagnosis.
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Trypanosoma cruzi is the causative agent of Chagas or American
Trypanosomiasis, a disease that affects around 8–10 million people
in Latin America [1]. In non-endemic areas, and in the absence of
blood transfusion risks, the T. cruzi congenital transmission
infection is increasing its epidemiological importance, because,
according to epidemiological studies, more than 15,000 new
infected babies are expected each year, and besides, the migration
of T. cruzi infected women, mainly to North America and Europe,
makes the Chagas congenital transmission a worldwide health
problem [2].
The mother-to-child T. cruzi transmission rate in different
endemic areas is variable: 10% in Paraguay [3], 3.4–8.6% in
Bolivia [4–6], 2.3% in Chile [7], 1.4% in Brazil [8], and 7–11% in
Argentina [9–11]. Sometimes these vertical transmission rates are
underestimated, as a high percentage of children do not complete
the necessary one-year follow-up to confirm T. cruzi infection
[3,9,12–14].
The early diagnosis in infants born to seropositive women
depends on the detection of blood parasites, when maternal T.
cruzi antibodies could still be present. Ten months after delivery,
the detection of specific antibodies in babies by at least two or
three serological assays confirms the congenital transmission of the
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parasite [11,2]. The failure to detect parasites in T. cruzi-infected
newborns at one month of age could probably be due to a low
sensitivity of the assay. This fact, in addition to the necessary one-
year follow-up to diagnose this infection, claims for more sensitive
screening methods to detect T. cruzi infected babies at birth in
endemic areas.
By using a quantitative PCR, we have previously demonstrated
that the parasite burden of non-pregnant women was not
significantly different from that of T. cruzi-seropositive women
pregnant with healthy children, and that parasitemia levels of
women pregnant with T. cruzi-infected children increased about
six-fold compared with that of the other two above mentioned
groups of women studied [15].
In this study, we estimated the T. cruzi parasite burden by
quantitative DNA amplification, in children diagnosed by INP
micromethod at 1 and 6 months after delivery and by serology
after 10 months of age. We also correlated values of parasitemia
and ELISA serology in this third group of children and genotyped
the isolated parasites, with the aim to further understand the
congenital transmission of T. cruzi and improve the early diagnosis




Pregnant women and their newborns were diagnosed for T.
cruzi infection at the Instituto Nacional de Parasitologı´a (INP) ‘‘Dr.
Mario Fatala Chaben’’-ANLIS ‘‘Carlos G. Malbra´n’’, the
reference center for diagnosis of this parasitosis in Argentina.
Pregnant women were interviewed, and when confirmed as
seropositive for T. cruzi infection, invited to diagnose their
newborns after delivery. Sixty percent of women included in this
study had been born in Argentina (half of them in the endemic
area, in the north of the country), whereas around 35% came from
Bolivia and 5% from Paraguay. All the infected pregnant women
were asymptomatic and in the chronic phase of T. cruzi infection,
resided in a non-endemic area, did not travel to the endemic area,
did not receive any blood transfusions in the year before the study,
and had not been previously treated with trypanocidal drugs.
Seropositive pregnant women (n = 843) gave birth to 95 T. cruzi
infected babies. The inclusion criteria for parasite burden study
were that children should visit our Institution for three controls
during one-year follow-up, or until they were diagnosed as T. cruzi
infected, and only 51 children fulfilled this requirement. Most of
them had GEB-blood samples available of three controls that were
submitted for qPCR analysis. When 95 children were diagnosed as
T. cruzi-infected, they were referred for trypanocidal treatment,
and samples from drug-treated children were not further
considered in this study.
T. cruzi serological diagnosis
Mothers and their babies were serologically diagnosed at the
INP 10 months after delivery, by three different tests: indirect
hemagglutination, indirect immunofluorescence and enzyme-
linked immunosorbent assay (ELISA), using epimastigote whole
homogenate as antigen, as previously described [15]. Patients were
considered T. cruzi infected when at least two of the serological
tests were positive, according to the criteria of the World Health
Organization and the approved Argentinean guidelines. Babies of
1 and 6 months of age were also tested for T. cruzi serology to
measure specific antibodies and antibodies transferred from the
mother.
Parasitological diagnosis of T. cruzi infection in infants
Microscopic blood examination: INP micromethod. Peri-
pheral blood from babies born to T. cruzi-seropositive women was
obtained during three controls at 1, 6 and around 12 months of age
to detect T. cruzi infection. The INP micromethod [16] was carried
out to detect the presence of T. cruzi in the children’s blood. Briefly,
0.5 to 1.0 mL of heparinized blood was collected by venopuncture
in an Eppendorff tube, centrifuged for one minute and the buffy
coat between sera and blood cells was loaded in two slides with
coverslips of 22622 mm in size, and carefully examined by
microscopy at 4006 for at least 30 minutes. This method proved
to have 68.9% sensitive in newborns, and additionally 31.1% in
infants at 6 month of age compared to xenodiagnosis [11].
Quantitative T. cruzi DNA amplification. 0.5 mL of
peripheral blood collected from children born to seropositive
mothers were mixed with the same volume of guanidine
hydrochloride 6M, EDTA 0.2 M, pH 8 (GEB) (Sigma Chemical
Co., St Louis, MO, USA), kept at room temperature for 1 week
and then at 4uC until use. A volume of 0.2 mL of blood-GEB was
used for DNA isolation using illustra blood Mini columns (GE
Healthcare Life Sciences, Uppsala, Sweden), according to the
manufacturer’s protocol. An internal standard of DNA extraction
(2 ng) was included in each GEB sample as previously described
[15]. Parasite quantification in DNA extracted samples was
performed in duplicate, in an ABI 7500 thermocycler (Applied
Biosystems, Carlsbad, CA, USA), amplifying a T. cruzi satellite
sequence flanked by the Sat Fw and Sat Rv oligonucleotides [17]
using the commercial kit SYBR GreenER qPCR SuperMix
Universal (Invitrogen, Life Technologies, Grand Island, NY,
USA). Briefly, 8 ml of DNA in 20 ml final volume reaction was
subjected to DNA amplification with the following profile: 50uC
for 2 min; 95uC for 10 min, and 40 cycles (95uC for 15 s, 60uC
for 60 s). The T. cruzi CL Brener clone was used to perform a
standard detection curve, spiking 106 epimastigotes/mL of a
seronegative blood sample - GEB mix, 10-fold diluted, and
extracted as mentioned above. The Cycle threshold (Ct) of each
sample after the real time PCR procedure allowed us to
interpolate the parasite equivalents from a standard curve of
known parasite concentrations [15]. The internal standard was
also amplified with the same thermoprofile. Several points of the
parasite curve, two positive samples, two negative samples and
non-template DNA were included in every qPCR run. The cut
off value of this method is 0,14 Pe/mL as was previously
described (15), obtained after a ROC (Receiver -operating
characteristic) analysis, using an available on line resource
www.medcalc.org.
Author Summary
Chagas or American Trypanosomiasis is a disease that
affects around 8–10 million people in Latin America, and
can be transmitted by congenital infection. In areas where
the vector insect and blood transfusions are controlled,
this mode of transmission is epidemiologically important,
as 15,000 Trypanosoma cruzi-infected children are born
each year. Parasitological methods are available to detect
T. cruzi but our results suggest that more sensitive
diagnostic methods should be developed, as not all
newborns have high parasite burdens to be detected by
microscopy. If congenital infected babies are promptly
diagnosed after delivery they can be cured, as the
trypanocidal treatment is very effective in children and
with no significant side effects.
T. cruzi diagnosis in congenital infection
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Parasite hemoculture
To isolate T. cruzi circulating parasites, 0.5 mL of infant blood
was distributed in one culture tube containing liver infusion
tryptose (LIT) medium supplemented with 10% fetal calf serum
and incubated at 28uC. Parasite growth was checked at 15, 30 and
45 days by microscopy and, when T. cruzi isolates were observed,
they were immediately frozen for preservation and maintained in
culture by weekly passages.
T. cruzi Discrete Typing Units (DTU) PCR genotyping
DNA was extracted from hemocultured and isolated parasites
with spin columns (GE Healthcare Life Sciences, Uppsala,
Figure 1. Flow diagram chart of the serological and parasitological studies in pregnant women and their infected children. T. cruzi
quantitative DNA amplification was retrospectively performed in three groups of congenitally infected children.
doi:10.1371/journal.pntd.0002476.g001
Table 1. Quantitative parasitemia in T. cruzi congenitally infected children.
Children diagnosed at A) 1 month of age B) 6 months of age C) 9–12 months of age
1st control by INP micromethod 1,789 (707–5,963)
2nd control by INP micromethod 21 (4–255) 545 (33–2,421)
3rd control by serology 5 (0.2–162) 800 (141–1,318) 24 (4–805)
Parasite burden by qPCR was a retrospective work after all infected babies were referred for trypanocidal treatment. Median parasitemia (interquartile range), expressed
as equivalent parasites per mL, of children diagnosed by parasitology at 1 or 6 months of age or by serology at around 12 months of age.
doi:10.1371/journal.pntd.0002476.t001
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Sweden). Parasites were PCR-genotyped targeting the intergenic
regions of spliced-leader genes with primers TCC, TC1 and TC2
[18], yielding DNA amplification products of 350 bp for TcI
parasites and 300 bp for TcII, TcIV and TcVI parasites. To
identify other parasite DTUs another PCR assay, targeting the
divergent domain of the 24S alpha rRNA gene with D71 and D72
primers was performed [19]. The reference strains Sylvio X10
(TcI), Y (TcII), M5631 (TcIII) CANIII (TcIV), Mncl2 (TcV) and
CL-Brener (TcVI) were used.
Statistical analysis
Data were presented as the medians within interquartile ranges
when non-normally distributed. Differences between groups were
examined by the Kruskal–Wallis test and the Dunn post-test for
multiple comparisons, using GraphPad Prism 5 software (Graph-
Pad Software, La Jolla, CA, USA). Pearson’s rank correlation was
used to evaluate correlations between the variables. A p value of
,0.05 was considered statistically significant. The qPCR cut-off
was obtained by analysis of a receiver-operating characteristic
(ROC) curve, using the Med-Calc statistical software, version
11.5.0.0 as previously described [15].
Ethics statement
This study was approved by the Ethics Committee of the
ANLIS ‘‘Carlos G. Malbra´n’’ and carried out according to the
declaration of Helsinki. Informed written consent was obtained
from all pregnant women included in the study before blood
collection, who also have provided consent to involve their
children in this study.
Results
Pregnant women and T. cruzi infected children
A total of 1,742 pregnant women requested serology for T. cruzi
infection at the INP ‘‘Dr. Mario Fatala Chaben’’, from 2008 to
2011, 48.39% of which were diagnosed as sero-reactive. We
recorded a rate of congenital parasite transmission of 11.26%, as
95 T. cruzi-infected infants were born to 843 seropositive mothers.
Only 51 of these children were one year followed-up in our
Institution for three controls (Fig. 1), at 1, 6 and around one year
after delivery, according to the recommended guides for the
diagnosis of congenital T. cruzi transmission infection, and we
submitted for qPCR analysis GEB-blood samples from these 51
infected infants.
T. cruzi parasite burden quantitation in three groups of
infants
Infant blood samples were available at three different times of T.
cruzi diagnosis: Group A): samples from neonates (n = 19) that
were diagnosed within the first month after delivery by INP
micromethod observation of bloodstream parasites Group B):
samples from infants (n = 10) that required a second visit for
parasitological diagnosis at six months of age and Group C):
samples from babies (n = 22) diagnosed by specific anti-T. cruzi
serology at around 1 year of life. Child blood samples were
intended to be collected in every visit, so we had only one sample
from each infant of Group A, who were then referred for
trypanocidal treatment, we had in some cases, two samples from
each child of Group B at 1 and 6 months of age, and three blood
samples of each child of group C (Fig. 1 and Table 1).
A quantitative PCR (qPCR) previously set up in our laboratory
was performed to determine the parasitic loads in infant blood
samples.
Comparison of the bloodstream parasitic loads obtained in the
three groups of children (Table 1) showed that group A neonates
presented the highest levels of parasite burden 1,789 Pe/mL,
(equivalent amounts of parasite DNA per mL) (Fig. 2 and 3a).
Babies from group B, diagnosed as T. cruzi-positive at 6 months of
age, showed a lower median parasitemia (21 Pe/mL) (Fig. 2 and
3b). Children from group C, with negative parasitemia by INP
micromethod but diagnosed by serology at around 1 year old,
exhibited the lowest parasitemia of all groups studied (5 Pe/mL)
(Fig. 2 and 3c).
As shown in Table 1, Fig. 3b and Fig. 3c, children of groups B and
C, who were negative for parasitological screening at 1 month of age,
exhibited a higher parasitemia at 6 months of age (545 Pe/mL for
group B and 800 Pe/mL for group C than that observed at 1 month
of age. In group C, children serologically diagnosed at around 1 year
old showed a parasite burden of 24 Pe/mL, a low parasitemia level,
similar to that of these babies when they were one month old (Fig. 3c).
It is worth noting that, taking into account the three controls during
the one-year follow-up, the parasite burden of serologically
diagnosed children of group C inversely correlated (r = 0,49) with
the increment of ELISA antibodies titers, at 6 and 12 months old
(Fig. 3d).
All infected infants were referred for tripanocidal treatment on
the basis of parasitological diagnosis (first and second controls) or
serodiagnosis (third control). Some of these treated children
returned for a T. cruzi serology control, and when samples were
available for qPCR, the parasitic burden was undetectable, below
the detection limits of our quantitative method (,0.14 Pe/mL)
indicating parasitological response to treatment with Benznida-
zole.
T. cruzi DTU genotypification
Infecting T. cruzi parasites in 19 newborns under study were
isolated from venipuncture blood samples followed by hemocul-
ture in LIT medium. PCR genotyping showed that 18 of these
isolated parasites belonged to DTU TcV (former lineage TcIId).
Figure 2. T. cruzi bloodstream parasite burden in newborns
tested at their first month of age. In T. cruzi infected children
diagnosed in their first, second or third control, at 1, 6 months of age
and around 1 year old, repectively, parasitemia was quantified by qPCR
in the sample obtained at the 1st month of age. Significant differences
were found in the median of the three groups assayed, by Kruskal–
Wallis test using GraphPad Prism 5 software.
doi:10.1371/journal.pntd.0002476.g002
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Parasitemia could not be quantified when the sample was available
at 1 month of age only in 1 out of 19 children, but we succeeded in
isolating the infecting parasite by hemoculture. PCR genotyping
showed that this parasite belonged to DTU TcI.
Discussion
The aim of this study was to further understand why not
every neonate born to T. cruzi-infected mothers can be
diagnosed by microscopy observation of blood samples imme-
diately after birth. Here, we demonstrated that only infants with
very high parasitemia can be diagnosed by parasitology
screening at 1 month of age, although the high efficiency
exhibited by the INP micromethod, resulted in 94% sensitivity
in a complete children one-year follow-up [11]. Those babies
that had to return at 6 months of age for T. cruzi infection
control were successfully diagnosed by INP micromethod
observation when parasitemia increased at 6 months of age
(Fig. 3b). In addition, the fact that some of the babies could only
be diagnosed by serology at around 1 year old was because their
parasitemia levels were under the sensitivity of the parasitolog-
ical INP micromethod.
In congenitally T. cruzi-infected children parasitemia is usually
higher than that detected in their chronic infected mothers [15],
but the values of infant parasitemia is highly variable. Here, we
found high parasite burdens, similar to those reported by other
research groups that quantified parasitemia in congenitally
infected children [20,13] in 76 and 80% of newborns studied
respectively, but certainly higher than those reported by others
[21,22], which handled lower number of samples and with low
parasitemia. In some of our infant samples, showing a very high
parasitemia, we confirmed values by DNA dilutions from 10 to
100 fold, to rule out dimers of satellite amplifications [17].
Moreover, our qPCR method reproduced the relationships of
Cycle thresholds (Cts) and spiked blood with known parasite
concentrations previously reported [17,21].
Hemoculture is labor and time consuming and parasites must
adapt to the culture medium, and it is less sensitive than molecular
diagnosis methods. The fact that we successfully isolated infecting
parasites in infants with very low parasitemia, expresses the
uneven distribution of few parasites in a very small volume of
blood sample.
Regarding parasite DTU genotyping, 18 out of 19 the parasites
isolated from T. cruzi-infected babies were TcV, in accordance to
Figure 3. T. cruzi bloodstream parasite burden in infants followed-up during their first year of life. Parasitemia was quantified by qPCR in
infants from group A (diagnosed at 1 month of age) (Fig. 3a); from group B (diagnosed at 6 months after delivery) (Fig. 3b); and from group C
(diagnosed at around 1 year old (Fig 3c), as explained in Material and Methods. Fig. 3d shows a correlation of the parasitemia of Fig. 3c with the
increment of ELISA antibodies titers (dashed line), tested at 6 and after 9 months of age.
doi:10.1371/journal.pntd.0002476.g003
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results by a pioneer work of Virreira et al. [20] in Bolivia, and by
Corrales et al. [23] in northwestern Argentina, in 34 and 18 blood
samples of congenitally infected children, respectively. However,
we found only one child with T. cruzi DTU I, who exhibited a very
low parasitemia, having amplified a satellite DNA. Besides, we
have previously genotyped 40 parasites isolated by hemoculture
from pregnant women, mothers of T. cruzi-infected and non-
infected children. All parasites in pregnant women were genotyped
as TcV, so we found no correlation between genotype and
transmission of T. cruzi infection, as reported by others [20,24]
when parasite genotyping was performed in areas of Northern
Argentina, Bolivia and Paraguay.
New and more sensitive methods for the detection of T. cruzi
parasites in infected newborns are needed because results of
microscopic observation of blood samples are highly dependent on
the operator, the time of observation and parasite motility, among
others. DNA amplification of T. cruzi parasites is emerging as a
gold standard that should hopefully be soon established as a
routine method in maternity hospitals. Kinetoplast DNA seems to
be a more suitable T. cruzi target to be amplified, because the
amount of this DNA is conserved among the different DTUs. In
the case of TcI parasites, the number of satellite sequences has
been reported to be around 10 per cent, regarding other DTUs
[17].
This parasite burden quantification in babies in three controls
during a one-year follow-up explains the difficulties to succeed in
diagnosing the parasite immediately after birth and stresses the
need to increase the sensitivity of new parasitological diagnosis
methods, for the prompt and effective trypanocidal treatment of
congenitally infected children.
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